Olema Pharmaceuticals (OLMA) Stock Chart & Stock Price History $6.33 +0.12 (+1.93%) Closing price 04:00 PM EasternExtended Trading$6.38 +0.05 (+0.77%) As of 04:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Olema Pharmaceuticals Stock Price Performance 5 Day Performance+5.13%1 Month Performance+11.50%3 Month Performance-46.22%6 Month Performance-60.01%Year-To-Date Performance+7.29%1 Year Performance-48.09% Receive OLMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Olema Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address OLMA Stock Chart for Thursday, January, 30, 2025 OLMA Chart by TradingView Olema Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/29/2025$6.02$6.21+3.16%$6.30$5.721.82 million shs$355.83 million01/28/2025$6.16$6.02-2.27%$6.29$5.861.79 million shs$344.95 million01/27/2025$5.95$6.16+3.53%$6.46$5.882.38 million shs$352.97 million01/24/2025$5.85$5.95+1.71%$6.08$5.66656,826 shs$340.94 million01/23/2025$5.68$5.85+2.99%$5.86$5.52613,070 shs$335.21 million01/22/2025$5.50$5.68+3.27%$5.77$5.46509,777 shs$325.46 million01/21/2025$5.66$5.50-2.83%$5.93$5.491.07 million shs$315.15 million01/20/2025$5.66$5.66$5.79$5.241.70 million shs$324.32 million01/17/2025$5.28$5.66+7.20%$5.79$5.241.70 million shs$324.32 million01/16/2025$5.52$5.28-4.35%$5.83$5.201.37 million shs$302.54 million Get the Latest News and Ratings for OLMA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Olema Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 01/15/2025$5.14$5.52+7.39%$5.54$5.161.17 million shs$316.29 million01/14/2025$4.84$5.14+6.20%$5.44$4.781.41 million shs$294.51 million01/13/2025$5.04$4.84-3.97%$5.05$4.60981,563 shs$277.32 million01/10/2025$5.75$5.04-12.35%$5.62$4.941.18 million shs$288.78 million01/09/2025$5.75$5.75$5.94$5.162.18 million shs$329.46 million01/08/2025$5.24$5.75+9.73%$5.94$5.162.18 million shs$329.46 million01/07/2025$5.50$5.24-4.73%$5.55$5.062.39 million shs$300.24 million01/06/2025$5.89$5.50-6.62%$6.00$5.481.05 million shs$315.14 million01/03/2025$5.57$5.89+5.75%$6.00$5.481.33 million shs$337.49 million01/02/2025$5.83$5.57-4.46%$6.08$5.43905,105 shs$319.15 million01/01/2025$5.83$5.83$5.98$5.582.08 million shs$334.05 million12/31/2024$5.61$5.83+3.92%$5.98$5.582.08 million shs$334.05 million12/30/2024$6.15$5.61-8.78%$6.15$5.591.75 million shs$321.44 million Related Companies RCUS Stock Price Chart DAWN Stock Price Chart OCUL Stock Price Chart ARVN Stock Price Chart ANIP Stock Price Chart SPRY Stock Price Chart MRVI Stock Price Chart CALT Stock Price Chart ARDX Stock Price Chart AUPH Stock Price Chart Receive OLMA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Olema Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OLMA) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersHot Stock Alert! Biotech innovator on the NYSE announces breakthrough antiviral therapyA revolutionary antiviral drug is here! This breakthrough could mean viruses are unlikely to escape treatment....Smallcaps Daily | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredTrump’s back in the oval office. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Olema Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Olema Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
